businesswire | February 24, 2021
Symbio Robotics has announced its official launch which is armed with $30M. Being a pioneer in the manufacturing industry as it combined artificial intelligence (AI) and industrial robotics, now its goal is to modernize industrial manufacturing. The company will be working on giving new life to existing industrial robots through the above-mentioned combination of technology
Symbio’s strategy gives the introduction of SymbioDCS. It is an industrial robotics middleware and python programming framework. It thoroughly simplifies the programming of industrial robots to make them far more intelligent. SymbioDCS allows robot programmers to influence real-time sensor information and takes feedback from existing automation sensors. As a result of which, the well-programmed and managed industrial robots with SymbioDCS quickly learn and execute tasks. Those tasks increase efficiency, improve quality and reduce ergonomic hazards.
At the same time, Symbio is currently working with Nissan Motor Corporation and Toyota Motor Corporation along with other major companies. ACME Capital made the recent investment in partnership with existing investors which includes Andreessen Horowitz, Eclipse Ventures, and The House Fund.
At this event, Symbio CEO and co-founder mentioned that Symbio is doing the same for manufacturing in the same way that Windows did for DOS. Existing industrial manufacturing robots run proprietary programming languages. It makes them slow and cumbersome. Not only do these robots lack agility, they even lack the intelligence to make them do what they need to do. The technology is designed to fundamentally reframe these existing manufacturing pain points with the help of utilizing the best practices of AI and human-robot interaction.
Furthermore, automotive manufacturing is transforming. This transformation is driven by demand for differentiated offerings that have much faster product life cycles. As per the International Federation of Robotics, the automotive industry remains the largest adopter of robots globally. The significant investments made with the need to adopt modern manufacturing methods will encourage new, quicker competition, and raise demand for being significantly faster in the future.
Therefore, to meet this demand, industry incumbents are focused exclusively on the fully autonomous black box. But Symbio is focused on a different problem, which depicts building automation. This enables the best of human-machine collaboration. Its framework is supportive of the programmers that are already working in these environments. With these, Symbio is also designing the tools that will allow developers and domain experts to work in manufacturing and create high-end automation solutions. To bring new innovative solutions, they are building products that encourage AI strengths and human insight in a mutual way.
Symbio’s focus is also on providing generalized solutions that facilitate companies to adopt AI as a core competency. This means that AI solutions will appear differently. It is because the matter is not just about creating automation. It is about creating and providing the tools that strengthen teams to design novel solutions using AI technology.
prnewswire | January 15, 2021
Sandvik has gained a minority stake in the exclusive American programming organization Oqton, a main supplier of AI-controlled assembling arrangements that permits makers to oversee, upgrade, and computerize their assembling work processes.
"This investment is in line with our strategic agenda to broaden our offering in digital manufacturing. We are looking forward to working with Oqton and finding ways to expand our offering for increased customer productivity by creating new products that take advantage of Sandvik's extensive know-how about manufacturing processes and Oqton's AI-powered manufacturing solutions", says Stefan Widing, President and CEO of Sandvik.
Oqton gives a safe start to finish cloud-based assembling stage that joins information across the total assembling environment, from plan to creation, to coordinations. Their open and skeptic cloud-based stage empowers makers to work coordinated plants and oversee complex item blends, with lower stock and a rearranged store network.
"Oqton's solution targets inefficiencies and waste in the manufacturing workflow. We believe that our relationship with Oqton will give us further opportunities to define and reduce waste throughout the entire manufacturing process. We share the same desire to automate workflows and make our customers more efficient", says Mathias Johansson, President of the Design & Planning Automation division in Sandvik Manufacturing Solutions.
Established in 2017, Oqton has 60 representatives, the corporate base in San Francisco, USA, and three R&D focuses situated in Belgium, Denmark and China.
The relationship with Oqton will be overseen by Sandvik Manufacturing Solutions' division Design and Planning Automation, inside the business territory Sandvik Manufacturing and Machining Solutions. The measure of the venture was not revealed.
WuXi Biologics | June 09, 2020
WuXi Biologics a global company with leading open-access biologics technology platforms, announced that it has signed a 10-year lease for a clinical manufacturing facility (MFG18) in Cranbury, New Jersey.
The new clinical manufacturing facility will install total 6000 L bioreactors, Process Development (PD), Quality Control (QC) labs, along with supporting functions. The 66,000-square-foot facility is expected to become operational in late 2020 and will bring in up to 100 jobs to the region.
This news follows WuXi Biologics' recent purchase of land to build a new 107,000-square-foot clinical and commercial manufacturing facility in Worcester, Massachusetts, and the lease of a 33,000-square-foot site to establish a process development lab in King of Prussia, Pennsylvania.